Moderna slips 8% as Pfizer COVID shot forecast weighs on shares
Maddie Meyer/Getty Images News

Moderna (NASDAQ:MRNA) is off ~8% Monday after a Pfizer (PFE) executive earlier in the day gave a relatively low estimate of eligible Americans expected to get new COVID-19 shots.
Pfizer CFO David Denton said the pharma expects ~24% of eligible Americans to get a booster -- ~82M people.

JP Morgan's Chris Schott, who is neutral on Pfizer, said he expects their COVID treatment sales to become more predictable after 2023.


More on Moderna

Pfizer, Moderna And COVID Vaccine Patents: Implications Of Legal Cases
Moderna: Buy Before The Fall Covid-19 Wave
Pfizer sees 24% of eligible Americans getting COVID-19 boosters
The 'tripledemic' threat to be less severe this season
Moderna wins EU recommendation for updated COVID shot
Seeking Alpha's Quant Rating on Moderna